Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. My name is Rochelle, and I will be your ...

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of food-associated allergic and inflammatory diseases.

Immunosuppressive factors prevent killer T cells from defeating brain tumors that arise from primary breast cancer.

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of ...

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of ...

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system ...

The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...

CCR8 is highly expressed on immunosuppressive regulatory T cells (Tregs) in various solid tumors, making it a potential target to enhance antitumor immunity and the efficacy of cancer therapies, ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

From my colleague Jason Mast: The first ever patient has been treated with prime editing, a powerful technology for making ...